Pure Biologics Spólka Akcyjna
PUR.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 95 | PLN 662 | PLN 254 |
| % Growth | -100% | -85.6% | 160.6% | – |
| Cost of Goods Sold | PLN 46 | PLN 2,669 | PLN 6,069 | PLN 4,281 |
| Gross Profit | -PLN 46 | -PLN 2,574 | -PLN 5,407 | -PLN 4,027 |
| % Margin | – | -2,709.5% | -816.8% | -1,585.4% |
| R&D Expenses | PLN 38 | PLN 0 | PLN 23,787 | PLN 20,580 |
| G&A Expenses | PLN 0 | PLN 6,539 | PLN 8,028 | PLN 3,797 |
| SG&A Expenses | PLN 14,915 | PLN 6,539 | PLN 8,028 | PLN 3,797 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 2,616 | PLN 22,605 | PLN 11,247 | PLN 2,663 |
| Operating Expenses | PLN 12,337 | PLN 29,144 | PLN 19,275 | PLN 6,460 |
| Operating Income | -PLN 12,383 | -PLN 31,718 | -PLN 24,629 | -PLN 10,482 |
| % Margin | – | -33,387.4% | -3,720.4% | -4,126.8% |
| Other Income/Exp. Net | -PLN 806 | -PLN 3,976 | -PLN 974 | -PLN 1,283 |
| Pre-Tax Income | -PLN 13,189 | -PLN 35,694 | -PLN 25,603 | -PLN 11,765 |
| Tax Expense | PLN 0 | PLN 0 | PLN 769 | PLN 1,306 |
| Net Income | -PLN 19,435 | -PLN 35,694 | -PLN 26,372 | -PLN 13,071 |
| % Margin | – | -37,572.6% | -3,983.7% | -5,146.1% |
| EPS | -3.78 | -11.19 | -11.87 | -5.88 |
| % Growth | 66.2% | 5.7% | -101.9% | – |
| EPS Diluted | -3.78 | -11.19 | -11.87 | -5.88 |
| Weighted Avg Shares Out | 5,135 | 3,189 | 2,221 | 2,221 |
| Weighted Avg Shares Out Dil | 3,485 | 3,189 | 2,221 | 2,221 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 281 | PLN 199 | PLN 93 |
| Interest Expense | PLN 1,330 | PLN 3,833 | PLN 329 | PLN 227 |
| Depreciation & Amortization | PLN 140 | PLN 5,784 | PLN 2,497 | PLN 2,920 |
| EBITDA | -PLN 12,244 | -PLN 26,077 | -PLN 22,777 | -PLN 8,618 |
| % Margin | – | -27,449.5% | -3,440.6% | -3,392.9% |